rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2006-3-28
|
pubmed:abstractText |
Although randomized trials of cyclooxygenase-2 (COX-2) inhibitors have shown increased cardiovascular risk, studies of nonselective, nonsteroidal antiinflammatory drugs (NSAIDs) and acetaminophen have been inconsistent.
|
pubmed:grant |
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1524-4539
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1578-87
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:16534006-Acetaminophen,
pubmed-meshheading:16534006-Adult,
pubmed-meshheading:16534006-Aged,
pubmed-meshheading:16534006-Analgesics,
pubmed-meshheading:16534006-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:16534006-Cardiovascular Diseases,
pubmed-meshheading:16534006-Cyclooxygenase 2 Inhibitors,
pubmed-meshheading:16534006-Drug Evaluation,
pubmed-meshheading:16534006-Female,
pubmed-meshheading:16534006-Humans,
pubmed-meshheading:16534006-Middle Aged,
pubmed-meshheading:16534006-Prospective Studies,
pubmed-meshheading:16534006-Questionnaires,
pubmed-meshheading:16534006-Risk,
pubmed-meshheading:16534006-Risk Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events.
|
pubmed:affiliation |
Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. achan@partners.org
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|